[51, 52] However, there are still certain patients who benefit from node dissection such as young patients in which chemotherapy is associated with survival benefit in node positive disease and in ER+ breast cancer in which CDK4/6 inhibitor may be of benefit[53, 54]. Here, CDK4 is linked to breast cancer.